There is no cure for yellow fever, but the disease can be treated to make a person more comfortable. Most patients recover in three to four days. However, around 15% of people who contract yellow fever return to the first phase of the illness and experience relapse, a return of the high fever, abdominal pain, vomiting, and jaundice. The patient may also develop bleeding and kidney damage. Approximately 30,000 people die every year from yellow fever-related illnesses. Although the disease is usually curable, most cases resolve on their own within a week. About one in seven people will only have mild symptoms for a day or two. The remaining people will develop a more serious case, with high fever, jaundice, bleeding, shock, organ failure, and death. Vaccination is the only way to prevent yellow fever from becoming more severe. It is recommended that individuals get vaccinated against yellow fever if they plan to visit tropical countries like Africa or South America.
𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝗧𝗶𝗺𝗲 𝗢𝗳𝗳𝗲𝗿!
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗧𝗼 𝗔𝘃𝗮𝗶𝗹 𝗙𝗹𝗮𝘁 𝟯𝟬% 𝗢𝗙𝗙
Major players operating in the global yellow fever treatment market include GlaxoSmithKline plc, Regeneron Pharmaceuticals, Inc., Bausch Health, Cleveland Clinic, Pfizer Inc., Signify Holding, Bayer AG, Weyer GmbH, Ningbo David Medical, Natus Medical Incorporated, Ibis Medical, GENERAL ELECTRIC COMPANY, avihealthcare, Atom Medical Corp, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., CSL Limited, Sanofi, Merck & Co., Inc., BIOCRYST PHARMACEUTICALS, INC., and Tychan Pte. Ltd.
Key Market Drivers:
The increasing incidence of yellow fever in the world is the major factor that is expected to augment the growth of the global yellow fever treatment market. For instance, according to World Health Organization, yearly around 200,000 cases of yellow fever occur globally. It is important to diagnose yellow fever quickly. The symptoms are often mild or insignificant, but serious cases can lead to internal bleeding or death. A blood test can help confirm the infection. Patients with symptoms of the disease need supportive care for three to four days. There is a high chance that they will recover on their own. A doctor will monitor the patient’s health and treat any secondary infections. The best course of treatment depends on the severity of the infection. Increasing advancements in treatment options related to yellow fever are estimated to enhance the growth of the global yellow fever treatment market.
Covid-19 Impact Analysis:
During the COVID-19 pandemic, the attention towards other health issues got reduced, which affected the growth of the global yellow fever treatment market. Moreover, several healthcare challenges such as increasing COVID-19 cases and researches focusing on finding accurate treatment options for COVID-19 also affected the market growth.
- Africa is expected to hold a major share of the global yellow fever treatment market, owing to the increasing prevalence of yellow fever in the region. For instance, according to BioMed Central, around 90% of the total global cases of yellow fever occur in Africa.
- South America is estimated to witness high growth in the global yellow fever treatment market, owing to the increasing rate of yellow fever in the region. For instance, according to the National Institutes of Health (NIH), around 115 yellow fever cases occur every year in South America.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4774
Major Players Are: Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Yellow Fever Treatment Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Yellow Fever Treatment Industry Impact
Chapter 2 Global Yellow Fever Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Yellow Fever Treatment (Volume and Value) by Type
2.3 Global Yellow Fever Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Yellow Fever Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Yellow Fever Treatment Market Analysis
Chapter 6 East Asia Yellow Fever Treatment Market Analysis
Chapter 7 Europe Yellow Fever Treatment Market Analysis
Chapter 8 South Asia Yellow Fever Treatment Market Analysis
Chapter 9 Southeast Asia Yellow Fever Treatment Market Analysis
Chapter 10 Middle East Yellow Fever Treatment Market Analysis
Chapter 11 Africa Yellow Fever Treatment Market Analysis
Chapter 12 Oceania Yellow Fever Treatment Market Analysis
Chapter 13 South America Yellow Fever Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Yellow Fever Treatment Business
Chapter 15 Global Yellow Fever Treatment Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027